Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Novartis Farma S.P.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 8, 2023
Approval ID: ba8ba83dd9d08330
Company: Novartis Farma S.P.A.
Type: Standard

Approval Details

Approval Id: ba8ba83dd9d08330
Drug Cima Aemps Name: DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 033178942IP
Holder Company Name: Novartis Farma S.P.A.
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/novartis-farma-spa
Authorization Date: 2023-11-08
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 160 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Novartis Farma S.P.A.
Company Detail Path: /organization/novartis-farma-spa

Company Information

Pharmaceutical Company Name: NOVARTIS FARMA SPA
Country Name: Italy
City Name: torre annunziata,napoli,country_it
Address: VIA PROVINCIALE SCHITI 131

Active Ingredients

VALSARTAN

160 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 8, 2023

Approval ID

ba8ba83dd9d08330

Type

Standard

Back to CIMA-AEMPS Approvals